For nearly 30 years, this fund has invested in the growth potential of the health-care sector. Its holdings span the globe and a range of industries, including health-care service providers, pharmaceutical and biotech firms that are developing innovative drugs and treatments, and manufacturers of medical devices.
Portfolio Manager
A checkup on the health-care sector
The latest perspective on the sector from Kelsey Chen.
Fund weightings vs. MSCI World Health Care Index (ND) (%) as of 12/31/11
| Putnam | MSCI | ||
|---|---|---|---|
| Overweight | Aetna | 4.80 | 0.66 |
| Baxter International | 4.54 | 1.18 | |
| Celgene | 4.22 | 1.31 | |
| Underweight | Bristol-Myers Squibb | 0.00 | 2.53 |
| AstraZeneca | 0.00 | 2.61 | |
| Roche | 0.07 | 5.03 | |
Weightings reflect actual holdings, which will vary over time.